Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▴	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
CNTX	Context Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$36.12M	n/a	-59.7%	n/a	-$0.38
COCP	Cocrystal Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.83M	n/a	-139.5%	n/a	-$0.78
COGT	Cogent Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$328.94M	n/a	-51.7%	n/a	-$2.16
CRBP	Corbus Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$78.54M	n/a	-53.2%	n/a	-$5.90
CRVS	Corvus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.28M	n/a	-25.0%	n/a	-$0.53
CTNM	Contineum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.98M	n/a	-23.0%	n/a	-$2.17
CTOR	Citius Oncology, Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$24.76M	n/a	-55.2%	n/a	-$0.34
CTXR	Citius Pharmaceuticals, Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$39.74M	n/a	-58.8%	n/a	-$3.38
CURX	Curanex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$4.23M	n/a	-37.7%	n/a	-$0.17
CVKD	Cadrenal Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.24M	n/a	-483.3%	n/a	-$6.64
CYDY	CytoDyn Inc. Manufacturing · Year ended 2026-05-31 · USD	n/a	-$42.70M	n/a	n/a	n/a	-$0.03
CYPH	Cypherpunk Technologies Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$4.82M	n/a	3.1%	n/a	$0.07
DCOY	Decoy Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.52M	n/a	-212.6%	n/a	-$129.10
DMAC	DiaMedica Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$32.77M	n/a	-58.4%	n/a	n/a
DMRA	Damora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$209.84M	n/a	-87.3%	n/a	$3.98
DRMA	Dermata Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.56M	n/a	-121.5%	n/a	-$8.16
DWTX	Dogwood Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.26M	n/a	-45.7%	n/a	-$7.13
DYN	Dyne Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$446.21M	n/a	-45.9%	n/a	-$3.47
EDSA	Edesa Biotech, Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$7.19M	n/a	-57.7%	n/a	n/a
ELDN	Eledon Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.62M	n/a	-56.3%	n/a	-$0.52
ELTX	Elicio Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.57M	n/a	n/m	n/a	-$2.58
ELVN	Enliven Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.69M	n/a	-22.6%	n/a	-$1.83
ENLV	Enlivex Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.24B	n/a	63.9%	n/a	$25.48
ENVB	Enveric Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.77M	n/a	-210.0%	n/a	-$36.24
EOCN	Galmed Pharmaceuticals Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$6.90M	n/a	43.7%	n/a	$2.39

Rows per page: 2550 100